Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (23) , 7013-7016
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProceedings of the National Academy of Sciences, 2011
- A targeted low molecular weight near-infrared fluorescent probe for prostate cancerBioorganic & Medicinal Chemistry Letters, 2010
- Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruptionCancer Letters, 2010
- A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small MoleculesJournal of the American Chemical Society, 2010
- Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cellsInternational Journal of Oncology, 2010
- Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate CancerJournal of Nuclear Medicine, 2009
- In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigenThe Prostate, 2009
- Structural Basis of Interactions between Human Glutamate Carboxypeptidase II and Its Substrate AnalogsJournal of Molecular Biology, 2008
- The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigenBioorganic & Medicinal Chemistry, 2007
- Structural Optimization of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II by Modification of the P1‘ Side ChainJournal of Medicinal Chemistry, 2006